期刊文献+

陇中黄土高原地区冠脉病变程度与血脂水平的初步研究 被引量:1

暂未订购
导出
摘要 目的:探讨陇中黄土高原地区冠脉病变程度与血脂水平之间的关系。方法:选择2004~2008年在我院行冠状动脉造影同时行总胆固醇(TC)、高密度脂蛋白胆固醇(HDIL-C)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)、TC/HDL-C、LDL-C/HDL-C、载脂蛋白A(ApoAl)、载脂蛋白B(ApoB)及载脂蛋白A/B(ApoAl/B)检查的病人681例。根据造影结果采用Gesini积分法分为重度病变组、轻度病变组和正常组,比较各组间的血脂情况。结果:重度病变组血脂异常情况较轻度病变组及正常组更常见。结论:HDL-C、ApoAl、ApoB、LDL-C/HDL-C与冠心病的发病显著相关,LDL-C/HDL-C与冠状动脉病变程度有显著的相关性,ApoAl、HDL-C与冠状动脉病变程度呈负相关。
出处 《中国社区医师(医学专业)》 2009年第12期171-172,共2页
  • 相关文献

参考文献4

二级参考文献25

  • 1刘梅颜,胡大一,杨绍辉,刘如辉,刘文红.高水平的纤维蛋白原与LDL/HDL比值对冠脉风险的联合评估价值探讨[J].中级医刊,2004,39(11):21-23. 被引量:9
  • 2吴兆苏,中华心血管病杂志,1997年,25卷,255页
  • 3吴兆苏,中华心血管病杂志,1997年,25卷,6页
  • 4董承琅 陶寿淇 陈灏珠.实用心脏病学[M]//第三版[M].上海:上海科学技术出版社,1994.898-899.
  • 5Hearn JA, Demaio SJ, Roubin GS, et al. Predictive value of lipoproten(a) and other serum; lipoproteins in the angiographic diagnosis of coronary artery disease[J].Am J Cardiol,1990,66:1176-1180.
  • 6Excutive Summary of the third report of the National Cholesterol Education program (NCEP) expert panel on detection, evalution, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ)[J].JAMA,2001,285:2486-2497.
  • 7Shepherd J cobbe SM, Ford T, Iskes CG, For the west of Scotland coronary prevention study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N Eng J Med,1995,333:1301-1307.
  • 8叶任高 陆再英.内科学[M]//第五版[M].北京:人民卫生出版社,2000.310-312.
  • 9Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: result of AFCAPS/TAXCAPS[J].JAMA,1998,279:1615-1622.
  • 10Scandinavian Simvastatin Survival, Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease[J].The Scandinavian Simvastatin Survival Study (4s)[J].Lancet,1994,344:1383-1389.

共引文献144

同被引文献16

  • 1Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascular- ization [ J ]. J Am Coil Cardiol,2008,51 (5): 538-545.
  • 2Serruys PW, Morice MC, Kappetein AP, et al. Pereutaneous coronary intervention versus eoronary-artery bypass grafting for severe coro- nary artery disease [ J ]. N Eng J Med, 2009, 360( 10 ): 961-972.
  • 3Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus pereutaneous with three-vessel disease and left main coronary disease:5-year follow up of the random,clinical SYN- TAX[J ]. Lancet, 2013. 381 (9867):629-638.
  • 4Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/ PCNA/SCAI/STS guideline for the diagnosis and management of Pa- tients with stable ischemic heart disease [J]. Circulation, 2012, 126 ( 25 ):354-471.
  • 5Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summa- ry: a report of the American college of cardiology foundation/American heart association task force on Practice guidelines and the society for cardiovascular angiography and interventions [J]. Circulation, 2011, 124(23):574-651.
  • 6Task FM, Montalescot G, Sechte MU, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the taskforce on the management of stable coronary artery disease of the European society of eardiology[ J ]. Eur Heart J, 2014, 35 (33) : 2260-2261.
  • 7Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease [J].Euro lnterv, 2005,( 2 ): 219-227.
  • 8Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study. 1971-1992. National Health and Nutrition Examination Survey [J]. JAMA, 2000, 28( 18): 2404-2410.
  • 9Hamsten A, Walldius G, Szamosi A, et al. Relationship of angiogra- phieally defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myoeardial infaretion[ J ]. Circu- lation, 1986,73(6):1097-1110.
  • 10Muller-Wietand D, Kotzka J, Krone W. Stabilization of atheroscle- rotiec plaque during lipid lowering[ J ].Curr Opin Lipidol, 1997,8 (6): 348-353.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部